H.R. 4332 (112th): Generic Drug Application Review Fairness Act of 2012
Mar 29, 2012
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on March 29, 2012, in a previous session of Congress, but was not enacted.
Frank Pallone Jr.
Representative for New Jersey's 6th congressional district
Read Text »
Last Updated: Mar 29, 2012
Length: 7 pages
About the bill
- Full Title
To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Last Action: May 30, 2012
- What is a bill?
The “H.R.” in “H.R. 4332” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
6 cosponsors (3R, 3D) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 4332 — 112th Congress: Generic Drug Application Review Fairness Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr4332
“H.R. 4332 — 112th Congress: Generic Drug Application Review Fairness Act of 2012.” www.GovTrack.us. 2012. April 18, 2015 <https://www.govtrack.us/congress/bills/112/hr4332>
|title=H.R. 4332 (112th)
|accessdate=April 18, 2015
|author=112th Congress (2012)
|date=March 29, 2012
|quote=Generic Drug Application Review Fairness Act of 2012